Floatz logo

Rizatriptan

Vestibular Migraine

Robert W. BalohSmall moleculePhase 2/3Dormant
B
58/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
46/ 100
Competitive Position
81/ 100

Competitive context

11 Active assets in the Vestibular Migraine cohort.

Asset / SponsorPhaseRating
VERAPAMIL SLOW RELEASE
Stanford University
Phase 4BB
Galcanezumab
Stanford University
Phase 4BB
Amitriptyline
Stanford University
Phase 4BB
VENLOR
Affiliated Hospital of Jiaxing University
Phase 4BB
PROPRANOLOL
Stanford University
Phase 4BB

View all 15 →

Same molecule, other indications

Rizatriptan is also rated in:

migraine disorderDormant
A
Indicative ·
80 / 100
View asset →
migraine without auraDormant
B
Indicative ·
62 / 100
View asset →
Migrainous VertigoDormant
B
Indicative ·
61 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →